OVID
Ovid Therapeutics Inc
2.30$
-1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 73.4% | 76.1% | 70.8% | 68.5% | 64.1% | 60.7% | 56.2% | 54.4% | 45.1% | 59.9% | 71.0% | 53.3% | |
| 45.9% | 18.8% | 23.4% | 25.1% | 14.6% | 28.5% | 25.9% | 36.7% | 32.3% | 8.7% | 41.7% | 4.9% | |
| 69.6% | 73.5% | 68.6% | 65.2% | 61.1% | 57.6% | 52.7% | 49.5% | 40.1% | 46.1% | 68.9% | 50.5% | |
| 0.2% | 0.1% | 0.1% | 0.2% | 0.2% | 0.1% | 0.0% | – | – | – | – | – | |
| 19.0% | 39.0% | 40.5% | 24.7% | 25.7% | 26.0% | 27.4% | 27.9% | 30.0% | 13.4% | 12.1% | 9.5% | |
| 6.9% | 8.0% | 6.8% | 12.0% | 11.3% | 11.4% | 11.4% | 11.5% | 10.6% | 5.5% | 7.0% | 4.3% | |
| 1.0% | 0.9% | 1.0% | 1.1% | 1.3% | 1.4% | 1.7% | 1.8% | 2.2% | 0.9% | 0.6% | 0.6% | |
| 1.0% | 2.6% | 2.7% | 4.0% | 2.6% | 3.5% | 2.4% | 5.1% | 2.7% | 1.3% | 3.9% | 1.8% | |
| 81.0% | 61.0% | 59.5% | 75.3% | 74.3% | 74.0% | 72.6% | 72.1% | 70.0% | 86.6% | 87.9% | 90.5% | |
| -210.0% | -192.9% | -220.0% | -238.0% | -287.4% | -330.2% | -385.2% | -412.3% | -519.0% | -213.1% | -150.1% | -152.5% | |
| 56.5% | 49.1% | 53.7% | 60.3% | 69.1% | 77.0% | 87.0% | 91.8% | 111.4% | 54.1% | 32.7% | 31.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.